Last week, Applied Biosciences announced the completion of a year-long strategic review of its business, wrapping up the process by filling positions among its senior management. But the review process apparently didn’t jump-start revenue growth for the molecular biology tools leader.

“The overall numbers aren’t going up,” said Tony White, CEO of Applera, ABI’s parent company. He said the company modified its revenue projections for FY 2005 to low single-digit growth, from its previous projection of mid-single digit growth.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.